Clinical trials
Enrolling by invitation Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Golden Leaf MedTec Co. Ltd | 2 |
| Dong Peng | 1 |
| Nanfang Li | 1 |
| Peking University | 1 |
| Qilu Pharmaceutical Co., Ltd. | 1 |
| The Third Xiangya Hospital of Central South University | 1 |
| The University of Hong Kong-Shenzhen Hospital | 1 |
| United Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 9 |
| Cardiovascular Diseases | 1 |
| Colorectal Neoplasms | 1 |
| Connective Tissue Diseases | 1 |
| Diabetes Mellitus | 1 |
| Disease | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Fatty Liver | 1 |
| Heart Diseases | 1 |
| Hyperaldosteronism | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.